Experimental combo for tough lymphoma shows promise but trial halted
Disease control
Terminated
This study tested whether adding an extra drug (ALLO-647) to standard chemotherapy before giving donor-made CAR T cells could help adults with hard-to-treat large B-cell lymphoma. Only 2 people enrolled before the trial was stopped early. The goal was to see if the combo improved…
Phase: PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:04 UTC